Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
Go back to Notable Call Buying Activity in Teva Pharma (TEVA) Continues -Susquehanna
December 1, 2017 2:42 PM EST
Susquehanna options strategist Alison Edwards notes continued bullish options flow in Teva Pharma (NYSE: TEVA), as investors sold 5k Dec 14 Calls at $1.83 closing to buy 7k Dec 15 Calls $for 1.10, opening. Trading makes investor long ~30k Dec 156 calls. Also today, investors bought 13k Jan 17.5... More
November 29, 2017 6:45 AM EST
Mizuho Securities raised its price target on Teva Pharma (NYSE: TEVA) to $16.00 (from $12.00) while maintaining a Neutral rating, following a model update fueled by conversations with management.
Analyst Irina Koffler notes a positive outlook on the shares, following conversations with management... More
November 27, 2017 9:03 AM EST
Teva Pharmaceutical Industries Ltd. (NYSE & TASE: TEVA) announced today a new organization and leadership structure aimed to achieve better commercial focus and drive value creation. The new structure will enable strategic alignment across the portfolio, across regions and between functions, leveraging scale, enhancing agility, extracting efficiencies and providing increased proximity to the markets. This new structure will be implemented effective immediately.
... More
November 27, 2017 8:27 AM EST
Teva Pharma (NYSE: TEVA) Says It Isn't Planning to Divest Oncology/Pain Assets, Reassessed Situation - Bloomberg
...
More
